Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors

Kirk L. Stevens, Michael J. Reno, Jennifer B. Alberti, Daniel J. Price, Laurie S. Kane-Carson, Victoria B. Knick, Lisa M. Shewchuk, Anne M. Hassell, James M. Veal, Stephen T. Davis, Robert J. Griffin, Michael R. Peel

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Abstract

A novel series of pyrazolo[1,5-b]pyridazines have been synthesized and identified as cyclin dependant kinase inhibitors potentially useful for the treatment of solid tumors. Modification of the hinge-binding amine or the C(2)- and C(6)-substitutions on the pyrazolopyridazine core provided potent inhibitors of CDK4 and demonstrated enzyme selectivity against VEGFR-2 and GSK3β.

Original languageEnglish
Pages (from-to)5758-5762
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume18
Issue number21
DOIs
StatePublished - Nov 1 2008

Keywords

  • CDK2
  • CDK4
  • Cancer
  • Cyclin-dependant kinase inhibitor
  • GSK3β
  • Pyrazolo[1,5-b] pyridazine
  • VEGFR-2

Fingerprint

Dive into the research topics of 'Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors'. Together they form a unique fingerprint.

Cite this